Statins as anticancer agents in the era of precision medicine
Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase
(HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of …
(HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of …
Statins as Anticancer Agents in the Era of Precision Medicine
J Longo, JE van Leeuwen, M Elbaz… - … : an official journal …, 2020 - pubmed.ncbi.nlm.nih.gov
Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase
(HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of …
(HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of …
Statins as Anticancer Agents in the Era of Precision Medicine.
J Longo, JE van Leeuwen, M Elbaz… - … Cancer Research: an …, 2020 - europepmc.org
Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase
(HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of …
(HMGCR), the rate-limiting enzyme of the mevalonate metabolic pathway. Multiple lines of …
Statins as Anticancer Agents in the Era of Precision Medicine
J Longo, JE van Leeuwen, M Elbaz… - Clinical Cancer …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Statins are widely prescribed cholesterol-
lowering drugs that inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the …
lowering drugs that inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the …
[PDF][PDF] Statins as Anticancer Agents in the Era of Precision
J Longo, JE van Leeuwen, M Elbaz, E Branchard… - Clin Cancer …, 2020 - researchgate.net
Since their approval by the FDA in the late 1980s, statins have revolutionized the clinical
management of high cholesterol. Statins are specific inhibitors of the mevalonate pathway …
management of high cholesterol. Statins are specific inhibitors of the mevalonate pathway …